DISORDERS OF THE HEMOSTASIS SYSTEM IN ACUTE RESPIRATORY DISEASES OF THE LUNG.
Abstrakti
The lungs actively participate in the processes of coagulation and fibrinolysis. In particular, lung tissue is a rich source of factors for the coagulation and anti-coagulation systems of the blood. Thromboplastin, heparin, tissue plasminogen activator, prostacyclins, thromboxane A2, are synthesized in the lungs. Fibrinolysis occurs in the lungs, with the formation of fibrin degradation products (FDP). The lungs are capable of extracting from the bloodstream not only fibrin, but also its degradation products, which are excessively formed during DIC. Therefore, platelet-neutrophil interactions play an important role in recruiting neutrophils to the lungs during lung injury and ARDS.
Lataukset
Lähdeviitteet
Thromb Haemost. Bronchoalveolar hemostasis in lung injury and acuterespiratory distress syndrome / G J Glas 1, K F Van Der Sluijs, M J Schultz, J-J H Hofstra,T Van Der Poll,M Levi // J Thromb Haemost 2013 Jan;11(1):17-25.
doi: 10.1111/jth.12047.
Abduvaliev A.R., Inoyatova F.Kh., Mirkomilov E.M. A method of inhibiting
t-helper 2 cells to prevent lung fibrosis that develops as a result of atypical
pneumonia in COVID-19 // Proceeding of Global Congress of Contemporary Study- A Multidisciplinary International Scientific Conference Hosted from Pune, M.S. India.- P.182-187. www.econferenceglobe.com.
Сушенцева Н.Н., Попов О.С., Апалько С.В. и др. Биобанк COVID-19:
особенности цитокинового профиля // Кардиоваскулярная терапия и
профилактика.- 2020.- Т.19(6).- С.191-195.
Сушенцева Н.Н., Попов О.С., Апалько С.В. и др. Биобанк COVID-19:
особенности цитокинового профиля//Кардиоваскулярная терапия и
профилактика.- 2020.- Т.19(6).- С.191-195.
Maher T.M. Beyond the diagnosis of idiopathic pulmonary fibrosis: the
growing role of systems biology and stratified medicine. Curr. Opin. Pulm. Med. 2013; 19: 460–465.
Thorax. The pulmonary physician in critical care 6: The pathogenesis of
ALI/ARDS/ G.J.Bellingan // Thorax 2002 Jun; 57(6):540-6./ doi:10.1136/ thorax. 57.6.540.
Роль лѐгких в системе гемостаза/ Арипов А.Н.1, Каюмов У.К.1 , Иноятова Ф.Х.2 , Хидоятова М.Р.1 // Клиническая лабораторная диагностика. 2021; 66(7) //dx.doi.org/10.51620/0869-2084-2021-66-7-411-416.
Bronchoalveolar hemostasis in lung injury and acute respiratory distress
syndrome/ G. J. Glas, K. F. Van Der Sluijs, M. J. Schultz, J.-J. H. Hofstra, T. Van Der Poll,– and M.L E V I // Eur Respir J. 2008; 32:1599–606/DOI: 10.1111/ jth. 12047.
Acute Respiratory Distress Syndrome/ Gordon R. Bernard// Am J Respir
Crit Care Med. 2005 Oct 1; 172(7): 798–806./doi: 10.1164/rccm.200504-663OE
Preexisting respiratory diseases and clinical outcomes in COVID-19: a
multihospital cohort study on predominantly African American population/
Prateek Lohia, Kalyan Sreeram, Paul Nguyen, Anita Choudhary, Suman Khicher, Hossein Yarandi, Shweta Kapur, M. Safwan Badr// Respiratory Research. 2020; 21:130/ dx.doi.org / 10.1186/s12931-021-01647-6.
Thrombin signalling and protease-activated receptors/Shaun R. Coughlin
// Nature 407, 258–2 13. Alexander Zarbock1, Kai Singbartl, Klaus Ley Complete reversal of acidinduced acute lung injury by blocking of platelet-neutrophil aggregation The Journal of Clinical Investigation 2006 Dec;116(12): 3211-. doi:10.1172/JCI29499. 64 (2000). // doi.org/10.1038/35025229.
The vascular endothelial growth factor (VEGF) / VEGF receptor system and its role under physiological and pathological conditions/ Hiroyuki Takahashi; Masabumi Shibuya // Clin Sci (Lond) 2005; 109: 227–41.// doi.org/ 10.1042/ CS20040370.
Alexander Zarbock1, Kai Singbartl, Klaus Ley Complete reversal of acidinduced acute lung injury by blocking of platelet-neutrophil aggregation The Journal of Clinical Investigation 2006 Dec;116(12): 3211-. doi:10.1172/JCI29499.
Preexisting respiratory diseases and clinical outcomes in COVID-19: a multihospital cohort study on predominantly African American population/Prateek Lohia, Kalyan Sreeram, Paul Nguyen, Anita Choudhary,Suman Khicher, Hossein Yarandi, Shweta Kapur, M. Safwan Badr// Respiratory Research. 2020; 21:130 / dx.doi.org/10.1186/s12931-021-01647-6.
Легочный сурфактант и его применение при заболеваниях легкихо./О.А. Розенберг// Общая реаниматология, 2007, III; 1.
Involvement of the lungs in the hemostatic system and its disorders in acute respiratory diseases./Tursunov D.X., Omonov A.А., Mo'ydinov O. X.// Научный Импуьс Международный научный журнал № 7 (100), часть 2 «Новости образования: исследование в XXI веке» .(2023);251-256 bet.
Differential impact of two doses of antithymocyte globulin conditioning on
lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation/Jiangying Liu, Lan-Ping Xu, Zhilei Bian,Ying-Jun Chang,Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang // Journal of Translational Medicine. 2015;13 // doi.org/ 10.1186/s12967-015-0748-x.
Tursunov, D., & Akbarkhodjaeva, Z. (2017). Risk factors of developing transient ischemic attack. Journal of the neurological sciences, 381, 1115.
Tursunov, D., & Akbarkhodjaeva, Z. (2017). Epidemiological condition of stroke in the world. Journal of the Neurological Sciences, 381, 1115.
Akbarkhodjaeva, Z. A., & Tursunov, J. (2017). Prevalence of stroke in the world. Journal of Stroke and Cerebrovascular Diseases, 26(4), 913-914.
Tursunov, D. (2018). Assessment of L-Dopa induced dyskinesia. Parkinsonism & Related Disorders, 46, e45.
Diagnostic features of hypercoagulation syndrome in type 2 diabetes: clinical lab insights. / A.A.Omonov.//International Multidisciplinary Research in Academic Science (IMRAS).//Volume.6, Issue: 07,November(2023) // 540-541 https://doi.org /10.5281/zenodo.10265201.
Modern approaches to the diagnostics, treatment and prevention of severe
community-acquired pneumonia in adults: a review / S.N. Avdeev, Boris Z. Belotserkovskiy, A.V. Dehnich, A.A. Zaytsev,R.S. Kozlov, D.N. Protsenko ,S.A. Ratchina, A.I. Sinopalnikov, S.V. Yakovlev, A.I. Yaroshetskiy. // Crit Care Med. 2000; 28:77–80//doi.org/10.21320/1818-474X-2021-3-27-46.18. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia/ M.J.Schultz1, J Millo, M Levi,C.E.Hack, G.J. Weverling, C.S.Garrard, T van der Poll // Thorax. 2004; 59:130–5/ doi:10.1136/thorax.2003.013888.
Activated protein C, protease activated receptor 1, and neuroprotection /John H Griffin1, Berislav V Zlokovicn3,Laurent O Mosnier 1.// Epub 2018 Jul 12;132(2):159-169.doi:10.1182/blood-2018-02-769026.
Активированный протеин С ослабляет легочную коагулопатию у пациентов с острым респираторным дистресс-синдромом/ АД Корнет1, Джей Джей Хофстра, АП Влаар, ПР Туинман, М Леви, А. Р. Гирбес, МДж Шульц А.Б. Гроенвельд, Бейшуйдзэн// Джей Тромб Хемост.2013 Май; 11 (5): 894-901.doi: 10.1111/jth.12179. 21. COVID–19-associated coagulopathy: An exploration of mechanisms / Meaghan E.Colling1 and Yogendra Kanthi2 // Vasc Med. 2020 10; 25(5):471-478 // doi:10.1177/1358863X20932640.
